1/18
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Aim of treatment
Prevent long term problems and damage
Symptom control
DAS 28 Score
Disease Activity Score - 28
Less than 2.1 = remission
3 months later
Active disease, DAS 28 6.0
What do you do?
Start a Biologic drug → eligible cause failed conventional DMARDs and DAS28 is over 5.1

DAS 28 - High disease state range
over 5.1

6 months later shes in remission with no side effects. Next steps
Check prognostic markers
poor prognostic markers (high CRP and ESR) = more active disease = more aggressive disease
Tapering drugs and why?
Reducing number of doses, dose or number of drugs slowly
Taper because it reduces the side effects
Side effects of steroids
osteoporosis
diabetes
weight gain
cataracts
pancreatitis
Tapering and Cessation of glucocorticoids
should be tapered as rapidly as clinically feasible
Main concern with NSAIDs
GI bleed
Do COX-2 inhibitors eliminate the risk of GI bleeds?
NO - only reduces
Cardiovascular risk associated with NSAIDs?
Increased risk of myocardial infarction and heart failure
Which NSAID had particularly high CV risk?
Rofecoxib
csDMARDs
Conventional synthetic DMARDs - methotrexate
What are TNF inhibitors?
Biologics that block TNF to reduce inflammation e.g.
adalimumab
etanercept
infliximab
High relapse rates when stopped com[pared to continuation
What drug inhibits IL-6?
Toclizumab
What drug inhibits IL-1?
Ankinra
What are JAK inhibitors?
sDMARDs that block intracellular signalling
e.g. baricitinib, tofacitinib
What does Rituximab do?
Depletes B-cells
Can biologics be stopped in remission?
Sometimes, but relapse risk exists